Stroke prevention in atrial fibrillation: Closing the gap

Saved in:
Bibliographic Details
Published in:The American heart journal 2019-04, Vol.210, p.29-38
Main Authors: Pokorney, Sean D., Gersh, Bernard J., Ahmad, Azhar, Al-Khatib, Sana M., Blank, Melanie, Coylewright, Megan, DiBattiste, Peter, Healey, Jeff S., Hedrich, Olaf, Hylek, Elaine M., Kline-Rogers, Eva, Peterson, Eric D., Mendys, Phil, Mirro, Michael J., Naccarelli, Gerald, Patel, Parashar, Ruff, Christian T., Rutman, Howard, Stockbridge, Norman, Temple, Robert, Granger, Christopher B.
Format: Article
Language:English
Subjects:
Abuse
Adhesion
Administration, Oral
Age
Alcohols
Anticoagulants
Anticoagulants - administration & dosage
Anticoagulants - adverse effects
Aspirin
Aspirin - administration & dosage
Atrial Fibrillation - complications
Atrial Fibrillation - diagnosis
Biomarkers
Bleeding
Cardiac arrhythmia
Clinical medicine
Clinical trials
Dabigatran - administration & dosage
Drug abuse
Drugs
Dyslipidemia
Electronic health records
Electronic medical records
Fees & charges
Fibrillation
Health risks
Health Services Misuse - statistics & numerical data
Hemorrhage
Hemorrhage - chemically induced
Humans
Hypertension
Insurance
International Normalized Ratio - statistics & numerical data
Medical personnel
Medical research
Medical treatment
Monitoring
Patients
Physicians
Prevention
Pyrazoles - administration & dosage
Pyridines - administration & dosage
Pyridones - administration & dosage
R&D
Research & development
Risk
Rivaroxaban - administration & dosage
Septal Occluder Device
Side effects
Stroke
Stroke - etiology
Stroke - prevention & control
Thiazoles - administration & dosage
Thromboembolism
Trauma
Values
Warfarin
Warfarin - administration & dosage
Warfarin - adverse effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2018.10.004